B02BX06 emicizumab
ATC group of level 5 – chemical substance · in plain English: medicines to stop bleeding
This site has the patient leaflet or the SPC of 2 medicines in this group.
Active substance: Emicizumab – all medicines with this substance, also in combinations.
Place in the ATC classification
- B Blood and blood forming organ drugs 1,013 medicines
- B02 Antihemorrhagics 196 medicines
- B02B Vitamin K and other hemostatics 180 medicines
- B02BX Other systemic hemostatics 28 medicines
- B02BX06 emicizumab 2 medicines
- B02BX Other systemic hemostatics 28 medicines
- B02B Vitamin K and other hemostatics 180 medicines
- B02 Antihemorrhagics 196 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Hemlibra 150 mg / ml solution for injection SPC | – |
| Hemlibra 30 mg / ml solution for injection | – |
Other groups of the same level
- B02BX04 romiplostim 4 medicines
- B02BX05 eltrombopag 16 medicines
- B02BX07 lusutrombopag 1 medicine
- B02BX09 fostamatinib 2 medicines
Other names of the ATC group
- Czech: B02BX06 Emicizumab
- German: B02BX06 Emicizumab
- Spanish: B02BX06 EMICIZUMAB
- German: B02BX06 Emicizumab
- Italian: B02BX06 EMICIZUMAB
- Polish: B02BX06 EMICIZUMAB
- Turkish: B02BX06 emicizumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group B02BX06
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.